BIOGEN INC.

Insider Reports History

Location
Cambridge, MA
Signature
BIOGEN INC. By: /s/ Michael Dambach, Vice President and Treasurer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BIOGEN INC.:

Company Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC 10%+ Owner Common Stock 17,652,466 $6,745,007 $0.3821 26 Sep 2023 By Biogen MA Inc.
REATA PHARMACEUTICALS INC Other* Class A common stock 0 $172.03 28 Jul 2023 Indirect

Insider Reports Filed by BIOGEN INC.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMO SANGAMO THERAPEUTICS, INC 26 Sep 2023 1 -$3,000,000 4 10%+ Owner 28 Sep 2023, 18:30
RETA REATA PHARMACEUTICALS INC 28 Jul 2023 0 $0 3 Other* 07 Aug 2023, 17:18
SGMO SANGAMO THERAPEUTICS, INC 29 Aug 2022 2 -$2,657,240 4 10%+ Owner 31 Aug 2022, 19:03
SGMO SANGAMO THERAPEUTICS, INC 28 Dec 2021 1 -$23,522 4 10%+ Owner 30 Dec 2021, 16:12
SGMO SANGAMO THERAPEUTICS, INC 23 Dec 2021 2 -$699,666 4 10%+ Owner 28 Dec 2021, 07:11
SGMO SANGAMO THERAPEUTICS, INC 09 Dec 2021 1 -$202,541 4 10%+ Owner 10 Dec 2021, 15:08
SGMO SANGAMO THERAPEUTICS, INC 07 Dec 2021 2 -$1,099,265 4 10%+ Owner 09 Dec 2021, 15:08
SGMO SANGAMO THERAPEUTICS, INC 01 Dec 2021 2 -$22,166 4 10%+ Owner 03 Dec 2021, 15:09
SGMO SANGAMO THERAPEUTICS, INC 26 Nov 2021 1 -$248,434 4 10%+ Owner 30 Nov 2021, 15:20